Clinical Research Sequencing Platform, LLC

Website
415 Main St
Cambridge, MA 02142
https://www.broadinstitute.org

Clinical Research Sequencing Platform, LLC, located in Cambridge, MA, is dedicated to advancing the understanding and treatment of various diseases through innovative research and collaboration. The organization brings together experts in genetics, biology, artificial intelligence, and therapeutic development to drive significant discoveries in biomedical science.

With a focus on patient-partnered research and partnerships with pharmaceutical and biotech companies, the platform aims to accelerate the translation of scientific discoveries into effective treatments. Its facilities, including the Broad Discovery Center, foster an environment of interdisciplinary collaboration, where art and science intersect to enhance public engagement and education.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

LabCentral
Commercial research laboratory, Business services, nec, nec, Testing laboratories

LabCentral

LabCentral is a pioneering shared laboratory space in Cambridge, serving as a strategic platform for emerging life sciences and biotech startups to thrive. Designed as a launchpad for high-potential ventures, LabCentral offers a unique environment for innovation and collaboration within the industry. Generated from their website's infomation
Drugs acting on the respiratory system, Blood derivatives, Surgical instruments and apparatus

Relay Therapeutics

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.
Testing laboratories

Centogene

CENTOGENE is a leading life science company specializing in rare and neurodegenerative diseases, providing data-driven solutions to patients, physicians, and pharmaceutical companies. With a vast biodatabank of 800,000 individuals and 400,000 collected biosamples, they work collaboratively with patients, physicians, and partners to diagnose, understand, and treat these complex diseases. By integrating omic data and creating comprehensive atlases of rare diseases, CENTOGENE aims to diagnose patients accurately. They also focus on understanding disease pathways and faulty genes to provide valuable insights for pharmaceutical partners in developing targeted treatments. With their multiomic technologies, they identify drug targets with greater certainty, making drug development for rare diseases more financially viable. Their ultimate goal is to enable the cure of 100 diseases within a decade.Generated from the website
United States›Massachusetts›Cambridge›Clinical Research Sequencing Platform, LLC

Partial Data by Infogroup (c) 2024. All rights reserved.